Hangzhou Tigermed Consulting Co., Ltd.
HNGZY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $3,444,104 | $24,953,035 | $25,277,353 | $25,166,479 |
| - Cash | $231,532 | $1,732,879 | $1,505,267 | $2,055,345 |
| + Debt | $246,115 | $2,381,311 | $2,854,859 | $2,634,984 |
| Enterprise Value | $3,458,687 | $25,601,467 | $26,626,945 | $25,746,118 |
| Revenue | $248,054 | $1,686,301 | $1,564,144 | $1,535,505 |
| % Growth | -85.3% | 7.8% | 1.9% | – |
| Gross Profit | $68,130 | $508,218 | $469,761 | $271,731 |
| % Margin | 27.5% | 30.1% | 30% | 17.7% |
| EBITDA | $110,790 | $309,709 | $187,382 | -$288,345 |
| % Margin | 44.7% | 18.4% | 12% | -18.8% |
| Net Income | $89,012 | $217,868 | $165,469 | -$408,285 |
| % Margin | 35.9% | 12.9% | 10.6% | -26.6% |
| EPS Diluted | 0.1 | 0.25 | 0.19 | -0.47 |
| % Growth | -60% | 31.6% | 140.4% | – |
| Operating Cash Flow | $66,249 | $210,684 | $197,935 | $0 |
| Capital Expenditures | -$10,169 | -$52,737 | -$48,095 | -$78,493 |
| Free Cash Flow | $56,080 | $157,948 | $149,840 | $439,740 |